MW is a 5 1 yea r old fe male wit h a psychi a tric hist ory of recu rr ent seve re major d epression a nd a past m edi cal hi st ory of only mild ast hma. She had fail ed fluoxetine a nd fluvoxamine a fte r initial positive respon se; how ever, he r de pr essed mood woul d return in settings of severe psych osocial st ress . Whil e on a maxim u m dos e of f1uvoxam in e, she exp re ssed su icid al int ent. MW wa s thus adm itted for inpati ent ca re , wh ere sh e respond ed to ph enelzine.
Aft er hospitalizat ion, MW re m aine d sta ble on ph en el zin e; howeve r, she pr ese n te d afte r four months without m edi cation follow-up com plaining of pr ogr es sive swe lling. in all ex t re m ities. Sh e also com pla ine d of wors eni ng shortnes s of br eath , severe ly decr eased exe rcise toleran ce, a 50 pound weight gain and three-pill ow ort hopne a without ches t pain. C linical exam was unrem a rk a ble ex cept for th e afo re me ntione d ede ma. Complet e blood cou n t, e ryt hrocyt e sed im ent ation rat e, se ru m albumin, BUN/creatinin e, T SH a nd urin al ysis we re a ll normal. A hydroch olrothiazide trial fai led to bring her ede ma und er con t ro l.
Two months lat er, MW was refer red to psychi atry for co nti nue d managem e nt of her mood disord er a nd possible ph en elzin e di scontinuation . H er progressive "h eart failure-lik e" symptom atology had become so seve re th at she was a lmost e nt ire ly d ep end ent on others to provide basic se lf-ca re ; thus, a slow ta per from ph en elzine was sta r te d . Aft er being off of ph en elzin e for two we eks, MW not ed decr eased swelling in a ll ex tre m it ies with a return of full range of motion. H e r orthopn ea a nd exe rc ise tol erance had improved dramaticall y. Ment al stat us exa m ina tion at tha t tim e reveal ed near resolution of her mood sym ptoms . At her next follow up exa m ina tion 4 weeks lat er, sh e report ed cont in ue d symptom re mi ssion , with fu rther improvem ents not ed in her subj ective report of mood st at e a nd e ne rgy level as a result of con tinue d cor rect ion of ph en elzine-induced weight changes. She was follow ed clinically off of m edication.
The pa ti ent 's expe rie nce su ggest s th at th e ede ma associa ted wit h phenelzine ca n be quit e handicapping if all owed to pr ogress. Ou r cli nica l expe rie nce with ph enelzine has been very favorabl e, with our " typ ica l" case of drug-induced ede ma co ns is ting of lower ex t re m ity swe lling without sig nificant se qu ela e. This expe rie nce is lik ely share d by ot he r cl inicia ns who m ak e use of th is m edica t ion; howeve r, we should be for ewarned th at some pati ents may devel op severe, com plicat ed ede ma, pres enting health risks a nd physical morbidities th at ou twe ig h th erap eu tic be nefit.
